Phibro Animal Health | PAHC - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Align Technology USD 1B 103.43M 2025-09
ANI Pharmaceuticals USD 285.58M 22.98M 2025-12
Assertio Holdings USD 38.5M 8.59M 2025-09
Aurora Cannabis CAD 56.36M 39.33M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Canopy Growth CAD 371.32M 73.26M 2025-12
Corcept Therapeutics USD 120.49M 4.64M 2025-12
Eli Lilly USD 7.27B 2.52B 2025-12
Henry Schein USD 136M 9M 2025-09
Idexx Laboratories USD 180.07M 28.1M 2025-12
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Merck USD 18.17B 10.16B 2025-09
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Pacira USD 158.54M 10.96M 2025-12
Phibro Animal Health USD 55.49M 17.28M 2025-12
Prestige Brands USD 62.37M 56.73M 2025-12
Supernus Pharmaceuticals USD 151.37M 6.66M 2025-09
Zoetis USD 2.08B 649M 2025-09